Comparison of efficacy and safety of Prednisolone 20 mg vs Placebo in Diabetic patients with Complex Regional Pain Syndrome of upper extremity - PPDCRPS

Professor Jayantee Kalita0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•A) Continuous pain which is disproportionate to any inciting factor.
•B) At least one symptom in three of the four following domains.
•1) Sensory: hyperesthesia with or without allodynia.
•2) Vasomotor: Asymmetry in temperature or skin color, skin color changes of the affected limb.
•3) Sudomotor/edema: Presence of edema, sweating changes or sweating asymmetry.
•4) Motor/ trophic: Reduced range of motion or motor dysfunction with or without trophic changes of the limb.
•C). At least one sign in = 2 of the following domains.
•1) Sensory: Hyperalgesia (to pin prick) with or without allodynia (light touch, deep somatic presence or joint movements).
•2) Vasomotor: Evidence of temperature or skin color asymmetry, or skin color changes.
•3) Sudomotor/edema: edema, sweating changes or sweating asymmetry.
•4) Motor or trophic: Evidence of deduced range of movement, motor dysfunction (weakness, dystonia or tremor) and or trophic changes in nail, skin or hair.
•5) No other diagnosis could explain the symptoms or signs

•Patients with uncontrolled hypertension, diabetes, infection, organ
•failure, malignancy, shoulder joint dislocation or infection, pregnancy and unwilling for consent will be excluded

发起方

Professor Jayantee Kalita